1 Nonalcoholic Steatohepatitis Treatment Market Overview 1.1 Nonalcoholic Steatohepatitis Treatment Product Scope 1.2 Nonalcoholic Steatohepatitis Treatment Segment by Type 1.2.1 Global Nonalcoholic Steatohepatitis Treatment Sales by Type (2016 & 2021 & 2027) 1.2.2 Solid 1.2.3 Liquid 1.3 Nonalcoholic Steatohepatitis Treatment Segment by Application 1.3.1 Global Nonalcoholic Steatohepatitis Treatment Sales Comparison by Application (2016 & 2021 & 2027) 1.3.2 Hospital 1.3.3 Diagnostic Center 1.3.4 Specialized Clinic 1.3.5 Hospital Pharmacy 1.3.6 Drug Store 1.3.7 Mail Order Pharmacy 1.4 Nonalcoholic Steatohepatitis Treatment Market Estimates and Forecasts (2016-2027) 1.4.1 Global Nonalcoholic Steatohepatitis Treatment Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Nonalcoholic Steatohepatitis Treatment Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Nonalcoholic Steatohepatitis Treatment Price Trends (2016-2027) 2 Nonalcoholic Steatohepatitis Treatment Estimates and Forecasts by Region 2.1 Global Nonalcoholic Steatohepatitis Treatment Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Nonalcoholic Steatohepatitis Treatment Retrospective Market Scenario by Region (2016-2021) 2.2.1 Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Region (2016-2021) 2.2.2 Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Region (2016-2021) 2.3 Global Nonalcoholic Steatohepatitis Treatment Market Estimates and Forecasts by Region (2022-2027) 2.3.1 Global Nonalcoholic Steatohepatitis Treatment Sales Estimates and Forecasts by Region (2022-2027) 2.3.2 Global Nonalcoholic Steatohepatitis Treatment Revenue Forecast by Region (2022-2027) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 North America Nonalcoholic Steatohepatitis Treatment Estimates and Projections (2016-2027) 2.4.2 Europe Nonalcoholic Steatohepatitis Treatment Estimates and Projections (2016-2027) 2.4.3 China Nonalcoholic Steatohepatitis Treatment Estimates and Projections (2016-2027) 2.4.4 Japan Nonalcoholic Steatohepatitis Treatment Estimates and Projections (2016-2027) 2.4.5 Southeast Asia Nonalcoholic Steatohepatitis Treatment Estimates and Projections (2016-2027) 2.4.6 India Nonalcoholic Steatohepatitis Treatment Estimates and Projections (2016-2027) 3 Global Nonalcoholic Steatohepatitis Treatment Competition Landscape by Players 3.1 Global Top Nonalcoholic Steatohepatitis Treatment Players by Sales (2016-2021) 3.2 Global Top Nonalcoholic Steatohepatitis Treatment Players by Revenue (2016-2021) 3.3 Global Nonalcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nonalcoholic Steatohepatitis Treatment as of 2020) 3.4 Global Nonalcoholic Steatohepatitis Treatment Average Price by Company (2016-2021) 3.5 Manufacturers Nonalcoholic Steatohepatitis Treatment Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Nonalcoholic Steatohepatitis Treatment Market Size by Type 4.1 Global Nonalcoholic Steatohepatitis Treatment Historic Market Review by Type (2016-2021) 4.1.1 Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2016-2021) 4.1.2 Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Type (2016-2021) 4.1.3 Global Nonalcoholic Steatohepatitis Treatment Price by Type (2016-2021) 4.2 Global Nonalcoholic Steatohepatitis Treatment Market Estimates and Forecasts by Type (2022-2027) 4.2.1 Global Nonalcoholic Steatohepatitis Treatment Sales Forecast by Type (2022-2027) 4.2.2 Global Nonalcoholic Steatohepatitis Treatment Revenue Forecast by Type (2022-2027) 4.2.3 Global Nonalcoholic Steatohepatitis Treatment Price Forecast by Type (2022-2027) 5 Global Nonalcoholic Steatohepatitis Treatment Market Size by Application 5.1 Global Nonalcoholic Steatohepatitis Treatment Historic Market Review by Application (2016-2021) 5.1.1 Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2016-2021) 5.1.2 Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Application (2016-2021) 5.1.3 Global Nonalcoholic Steatohepatitis Treatment Price by Application (2016-2021) 5.2 Global Nonalcoholic Steatohepatitis Treatment Market Estimates and Forecasts by Application (2022-2027) 5.2.1 Global Nonalcoholic Steatohepatitis Treatment Sales Forecast by Application (2022-2027) 5.2.2 Global Nonalcoholic Steatohepatitis Treatment Revenue Forecast by Application (2022-2027) 5.2.3 Global Nonalcoholic Steatohepatitis Treatment Price Forecast by Application (2022-2027) 6 North America Nonalcoholic Steatohepatitis Treatment Market Facts & Figures 6.1 North America Nonalcoholic Steatohepatitis Treatment Sales by Company 6.1.1 North America Nonalcoholic Steatohepatitis Treatment Sales by Company (2016-2021) 6.1.2 North America Nonalcoholic Steatohepatitis Treatment Revenue by Company (2016-2021) 6.2 North America Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type 6.2.1 North America Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type (2016-2021) 6.2.2 North America Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type (2022-2027) 6.3 North America Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Application 6.3.1 North America Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Application (2016-2021) 6.3.2 North America Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Application (2022-2027) 7 Europe Nonalcoholic Steatohepatitis Treatment Market Facts & Figures 7.1 Europe Nonalcoholic Steatohepatitis Treatment Sales by Company 7.1.1 Europe Nonalcoholic Steatohepatitis Treatment Sales by Company (2016-2021) 7.1.2 Europe Nonalcoholic Steatohepatitis Treatment Revenue by Company (2016-2021) 7.2 Europe Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type 7.2.1 Europe Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type (2016-2021) 7.2.2 Europe Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type (2022-2027) 7.3 Europe Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Application 7.3.1 Europe 140 Sales Breakdown by Application (2016-2021) 7.3.2 Europe 140 Sales Breakdown by Application (2022-2027) 8 China Nonalcoholic Steatohepatitis Treatment Market Facts & Figures 8.1 China Nonalcoholic Steatohepatitis Treatment Sales by Company 8.1.1 China Nonalcoholic Steatohepatitis Treatment Sales by Company (2016-2021) 8.1.2 China Nonalcoholic Steatohepatitis Treatment Revenue by Company (2016-2021) 8.2 China Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type 8.2.1 China Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type (2016-2021) 8.2.2 China Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type (2022-2027) 8.3 China Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Application 8.3.1 China 312 Sales Breakdown by Application (2016-2021) 8.3.2 China 312 Sales Breakdown by Application (2022-2027) 9 Japan Nonalcoholic Steatohepatitis Treatment Market Facts & Figures 9.1 Japan Nonalcoholic Steatohepatitis Treatment Sales by Company 9.1.1 Japan Nonalcoholic Steatohepatitis Treatment Sales by Company (2016-2021) 9.1.2 Japan Nonalcoholic Steatohepatitis Treatment Revenue by Company (2016-2021) 9.2 Japan Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type 9.2.1 Japan Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type (2016-2021) 9.2.2 Japan Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type (2022-2027) 9.3 Japan Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Application 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021) 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Nonalcoholic Steatohepatitis Treatment Market Facts & Figures 10.1 Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales by Company 10.1.1 Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales by Company (2016-2021) 10.1.2 Southeast Asia Nonalcoholic Steatohepatitis Treatment Revenue by Company (2016-2021) 10.2 Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type 10.2.1 Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type (2016-2021) 10.2.2 Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type (2022-2027) 10.3 Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Application 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021) 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027) 11 India Nonalcoholic Steatohepatitis Treatment Market Facts & Figures 11.1 India Nonalcoholic Steatohepatitis Treatment Sales by Company 11.1.1 India Nonalcoholic Steatohepatitis Treatment Sales by Company (2016-2021) 11.1.2 India Nonalcoholic Steatohepatitis Treatment Revenue by Company (2016-2021) 11.2 India Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type 11.2.1 India Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type (2016-2021) 11.2.2 India Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type (2022-2027) 11.3 India Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Application 11.3.1 India Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Application (2016-2021) 11.3.2 India Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Nonalcoholic Steatohepatitis Treatment Business 12.1 AstraZeneca 12.1.1 AstraZeneca Corporation Information 12.1.2 AstraZeneca Business Overview 12.1.3 AstraZeneca Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2016-2021) 12.1.4 AstraZeneca Nonalcoholic Steatohepatitis Treatment Products Offered 12.1.5 AstraZeneca Recent Development 12.2 Arena Pharmaceuticals 12.2.1 Arena Pharmaceuticals Corporation Information 12.2.2 Arena Pharmaceuticals Business Overview 12.2.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Products Offered 12.2.5 Arena Pharmaceuticals Recent Development 12.3 GSK 12.3.1 GSK Corporation Information 12.3.2 GSK Business Overview 12.3.3 GSK Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2016-2021) 12.3.4 GSK Nonalcoholic Steatohepatitis Treatment Products Offered 12.3.5 GSK Recent Development 12.4 Novo Nordisk 12.4.1 Novo Nordisk Corporation Information 12.4.2 Novo Nordisk Business Overview 12.4.3 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Products Offered 12.4.5 Novo Nordisk Recent Development 12.5 Roche 12.5.1 Roche Corporation Information 12.5.2 Roche Business Overview 12.5.3 Roche Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Roche Nonalcoholic Steatohepatitis Treatment Products Offered 12.5.5 Roche Recent Development 12.6 Vivus 12.6.1 Vivus Corporation Information 12.6.2 Vivus Business Overview 12.6.3 Vivus Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Vivus Nonalcoholic Steatohepatitis Treatment Products Offered 12.6.5 Vivus Recent Development 12.7 Arisaph Pharmaceuticals 12.7.1 Arisaph Pharmaceuticals Corporation Information 12.7.2 Arisaph Pharmaceuticals Business Overview 12.7.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Products Offered 12.7.5 Arisaph Pharmaceuticals Recent Development 12.8 Cempra Pharmaceuticals 12.8.1 Cempra Pharmaceuticals Corporation Information 12.8.2 Cempra Pharmaceuticals Business Overview 12.8.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Products Offered 12.8.5 Cempra Pharmaceuticals Recent Development 12.9 Galectin Therapeutics 12.9.1 Galectin Therapeutics Corporation Information 12.9.2 Galectin Therapeutics Business Overview 12.9.3 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Products Offered 12.9.5 Galectin Therapeutics Recent Development 12.10 Galmed Pharmaceuticals 12.10.1 Galmed Pharmaceuticals Corporation Information 12.10.2 Galmed Pharmaceuticals Business Overview 12.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Products Offered 12.10.5 Galmed Pharmaceuticals Recent Development 12.11 Genfit 12.11.1 Genfit Corporation Information 12.11.2 Genfit Business Overview 12.11.3 Genfit Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Genfit Nonalcoholic Steatohepatitis Treatment Products Offered 12.11.5 Genfit Recent Development 12.12 Gilead 12.12.1 Gilead Corporation Information 12.12.2 Gilead Business Overview 12.12.3 Gilead Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Gilead Nonalcoholic Steatohepatitis Treatment Products Offered 12.12.5 Gilead Recent Development 13 Nonalcoholic Steatohepatitis Treatment Manufacturing Cost Analysis 13.1 Nonalcoholic Steatohepatitis Treatment Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Nonalcoholic Steatohepatitis Treatment 13.4 Nonalcoholic Steatohepatitis Treatment Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Nonalcoholic Steatohepatitis Treatment Distributors List 14.3 Nonalcoholic Steatohepatitis Treatment Customers 15 Market Dynamics 15.1 Nonalcoholic Steatohepatitis Treatment Market Trends 15.2 Nonalcoholic Steatohepatitis Treatment Drivers 15.3 Nonalcoholic Steatohepatitis Treatment Market Challenges 15.4 Nonalcoholic Steatohepatitis Treatment Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Nonalcoholic Steatohepatitis Treatment Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) Table 2. Global Nonalcoholic Steatohepatitis Treatment Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027) Table 3. Global Nonalcoholic Steatohepatitis Treatment Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Region (2016-2021) Table 5. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Region (2016-2021) Table 6. Global Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global Nonalcoholic Steatohepatitis Treatment Revenue Share by Region (2016-2021) Table 8. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) Forecast by Region (2022-2027) Table 9. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share Forecast by Region (2022-2027) Table 10. Global Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global Nonalcoholic Steatohepatitis Treatment Revenue Share Forecast by Region (2022-2027) Table 12. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) of Key Companies (2016-2021) Table 13. Global Nonalcoholic Steatohepatitis Treatment Sales Share by Company (2016-2021) Table 14. Global Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million) by Company (2016-2021) Table 15. Global Nonalcoholic Steatohepatitis Treatment Revenue Share by Company (2016-2021) Table 16. Global Nonalcoholic Steatohepatitis Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nonalcoholic Steatohepatitis Treatment as of 2020) Table 17. Global Nonalcoholic Steatohepatitis Treatment Average Price (US$/Unit) of Key Company (2016-2021) Table 18. Manufacturers Nonalcoholic Steatohepatitis Treatment Manufacturing Sites and Area Served Table 19. Manufacturers Nonalcoholic Steatohepatitis Treatment Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Type (2016-2021) Table 22. Global Nonalcoholic Steatohepatitis Treatment Sales Share by Type (2016-2021) Table 23. Global Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million) Market Share by Type (2016-2021) Table 24. Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit) by Type (2016-2021) Table 25. Global Nonalcoholic Steatohepatitis Treatment Sales Share by Type (2022-2027) Table 26. Global Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million) Market Share by Type (2022-2027) Table 27. Global Nonalcoholic Steatohepatitis Treatment Revenue Share by Type (2022-2027) Table 28. Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit) by Type (2022-2027) Table 29. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Application (2016-2021) Table 30. Global Nonalcoholic Steatohepatitis Treatment Sales Share by Application (2016-2021) Table 31. Global Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million) Market Share by Application (2016-2021) Table 32. Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit) by Application (2016-2021) Table 33. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Application (2022-2027) Table 34. Global Nonalcoholic Steatohepatitis Treatment Sales Share by Application (2022-2027) Table 35. Global Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million) Market Share by Application (2022-2027) Table 36. Global Nonalcoholic Steatohepatitis Treatment Revenue Share by Application (2022-2027) Table 37. Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit) by Application (2022-2027) Table 38. North America Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Company (2016-2021) Table 39. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share by Company (2016-2021) Table 40. North America Nonalcoholic Steatohepatitis Treatment Revenue by Company (2016-2021) & (US$ Million) Table 41. North America Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Company (2016-2021) Table 42. North America Nonalcoholic Steatohepatitis Treatment Sales by Type (2016-2021) & (K Units) Table 43. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2016-2021) Table 44. North America Nonalcoholic Steatohepatitis Treatment Sales by Type (2022-2027) & (K Units) Table 45. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2022-2027) Table 46. North America Nonalcoholic Steatohepatitis Treatment Sales by Application (2016-2021) & (K Units) Table 47. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2016-2021) Table 48. North America Nonalcoholic Steatohepatitis Treatment Sales by Application (2022-2027) & (K Units) Table 49. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2022-2027) Table 50. Europe Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Company (2016-2021) Table 51. Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share by Company (2016-2021) Table 52. Europe Nonalcoholic Steatohepatitis Treatment Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Company (2016-2021) Table 54. Europe Nonalcoholic Steatohepatitis Treatment Sales by Type (2016-2021) & (K Units) Table 55. Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2016-2021) Table 56. Europe Nonalcoholic Steatohepatitis Treatment Sales by Type (2022-2027) & (K Units) Table 57. Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2022-2027) Table 58. Europe Nonalcoholic Steatohepatitis Treatment Sales by Application (2016-2021) & (K Units) Table 59. Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2016-2021) Table 60. Europe Nonalcoholic Steatohepatitis Treatment Sales by Application (2022-2027) & (K Units) Table 61. Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2022-2027) Table 62. China Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Company (2016-2021) Table 63. China Nonalcoholic Steatohepatitis Treatment Sales Market Share by Company (2016-2021) Table 64. China Nonalcoholic Steatohepatitis Treatment Revenue by Company (2016-2021) & (US$ Million) Table 65. China Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Company (2016-2021) Table 66. China Nonalcoholic Steatohepatitis Treatment Sales by Type (2016-2021) & (K Units) Table 67. China Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2016-2021) Table 68. China Nonalcoholic Steatohepatitis Treatment Sales by Type (2022-2027) & (K Units) Table 69. China Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2022-2027) Table 70. China Nonalcoholic Steatohepatitis Treatment Sales by Application (2016-2021) & (K Units) Table 71. China Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2016-2021) Table 72. China Nonalcoholic Steatohepatitis Treatment Sales by Application (2022-2027) & (K Units) Table 73. China Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2022-2027) Table 74. Japan Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Company (2016-2021) Table 75. Japan Nonalcoholic Steatohepatitis Treatment Sales Market Share by Company (2016-2021) Table 76. Japan Nonalcoholic Steatohepatitis Treatment Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Company (2016-2021) Table 78. Japan Nonalcoholic Steatohepatitis Treatment Sales by Type (2016-2021) & (K Units) Table 79. Japan Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2016-2021) Table 80. Japan Nonalcoholic Steatohepatitis Treatment Sales by Type (2022-2027) & (K Units) Table 81. Japan Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2022-2027) Table 82. Japan Nonalcoholic Steatohepatitis Treatment Sales by Application (2016-2021) & (K Units) Table 83. Japan Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2016-2021) Table 84. Japan Nonalcoholic Steatohepatitis Treatment Sales by Application (2022-2027) & (K Units) Table 85. Japan Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2022-2027) Table 86. Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Company (2016-2021) Table 87. Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales Market Share by Company (2016-2021) Table 88. Southeast Asia Nonalcoholic Steatohepatitis Treatment Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales by Type (2016-2021) & (K Units) Table 91. Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2016-2021) Table 92. Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales by Type (2022-2027) & (K Units) Table 93. Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2022-2027) Table 94. Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales by Application (2016-2021) & (K Units) Table 95. Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2016-2021) Table 96. Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales by Application (2022-2027) & (K Units) Table 97. Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2022-2027) Table 98. India Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Company (2016-2021) Table 99. India Nonalcoholic Steatohepatitis Treatment Sales Market Share by Company (2016-2021) Table 100. India Nonalcoholic Steatohepatitis Treatment Revenue by Company (2016-2021) & (US$ Million) Table 101. India Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Company (2016-2021) Table 102. India Nonalcoholic Steatohepatitis Treatment Sales by Type (2016-2021) & (K Units) Table 103. India Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2016-2021) Table 104. India Nonalcoholic Steatohepatitis Treatment Sales by Type (2022-2027) & (K Units) Table 105. India Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2022-2027) Table 106. India Nonalcoholic Steatohepatitis Treatment Sales by Application (2016-2021) & (K Units) Table 107. India Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2016-2021) Table 108. India Nonalcoholic Steatohepatitis Treatment Sales by Application (2022-2027) & (K Units) Table 109. India Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2022-2027) Table 110. AstraZeneca Corporation Information Table 111. AstraZeneca Description and Business Overview Table 112. AstraZeneca Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 113. AstraZeneca Nonalcoholic Steatohepatitis Treatment Product Table 114. AstraZeneca Recent Development Table 115. Arena Pharmaceuticals Corporation Information Table 116. Arena Pharmaceuticals Description and Business Overview Table 117. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 118. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Table 119. Arena Pharmaceuticals Recent Development Table 120. GSK Corporation Information Table 121. GSK Description and Business Overview Table 122. GSK Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 123. GSK Nonalcoholic Steatohepatitis Treatment Product Table 124. GSK Recent Development Table 125. Novo Nordisk Corporation Information Table 126. Novo Nordisk Description and Business Overview Table 127. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 128. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Product Table 129. Novo Nordisk Recent Development Table 130. Roche Corporation Information Table 131. Roche Description and Business Overview Table 132. Roche Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 133. Roche Nonalcoholic Steatohepatitis Treatment Product Table 134. Roche Recent Development Table 135. Vivus Corporation Information Table 136. Vivus Description and Business Overview Table 137. Vivus Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 138. Vivus Nonalcoholic Steatohepatitis Treatment Product Table 139. Vivus Recent Development Table 140. Arisaph Pharmaceuticals Corporation Information Table 141. Arisaph Pharmaceuticals Description and Business Overview Table 142. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 143. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Table 144. Arisaph Pharmaceuticals Recent Development Table 145. Cempra Pharmaceuticals Corporation Information Table 146. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 147. Cempra Pharmaceuticals Description and Business Overview Table 148. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Table 149. Cempra Pharmaceuticals Recent Development Table 150. Galectin Therapeutics Corporation Information Table 151. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 152. Galectin Therapeutics Description and Business Overview Table 153. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Product Table 154. Galectin Therapeutics Recent Development Table 155. Galmed Pharmaceuticals Corporation Information Table 156. Galmed Pharmaceuticals Description and Business Overview Table 157. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 158. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Table 159. Galmed Pharmaceuticals Recent Development Table 160. Genfit Corporation Information Table 161. Genfit Description and Business Overview Table 162. Genfit Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 163. Genfit Nonalcoholic Steatohepatitis Treatment Product Table 164. Genfit Recent Development Table 165. Gilead Corporation Information Table 166. Gilead Description and Business Overview Table 167. Gilead Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 168. Gilead Nonalcoholic Steatohepatitis Treatment Product Table 169. Gilead Recent Development Table 170. Production Base and Market Concentration Rate of Raw Material Table 171. Key Suppliers of Raw Materials Table 172. Nonalcoholic Steatohepatitis Treatment Distributors List Table 173. Nonalcoholic Steatohepatitis Treatment Customers List Table 174. Nonalcoholic Steatohepatitis Treatment Market Trends Table 175. Nonalcoholic Steatohepatitis Treatment Market Drivers Table 176. Nonalcoholic Steatohepatitis Treatment Market Challenges Table 177. Nonalcoholic Steatohepatitis Treatment Market Restraints Table 178. Research Programs/Design for This Report Table 179. Key Data Information from Secondary Sources Table 180. Key Data Information from Primary Sources List of Figures Figure 1. Nonalcoholic Steatohepatitis Treatment Product Picture Figure 2. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type in 2021 & 2027 Figure 3. Type I Product Picture Figure 4. Type II Product Picture Figure 5. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application in 2021 & 2027 Figure 6. Hospital Examples Figure 7. Diagnostic Center Examples Figure 8. Specialized Clinic Examples Figure 9. Hospital Pharmacy Examples Figure 10. Drug Store Examples Figure 11. Mail Order Pharmacy Examples Figure 12. Global Nonalcoholic Steatohepatitis Treatment Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Nonalcoholic Steatohepatitis Treatment Sales Growth Rate (2016-2027) & (US$ Million) Figure 14. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) Growth Rate (2016-2027) Figure 15. Global Nonalcoholic Steatohepatitis Treatment Price Trends Growth Rate (2016-2027) (US$/Unit) Figure 16. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Region: 2016 VS 2021 Figure 17. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Region: 2021 VS 2027 Figure 18. North America Nonalcoholic Steatohepatitis Treatment Revenue (Million USD) Growth Rate (2016-2027) Figure 19. North America Nonalcoholic Steatohepatitis Treatment Sales (K Units) Growth Rate (2016-2027) Figure 20. Europe Nonalcoholic Steatohepatitis Treatment Revenue (Million USD) Growth Rate (2016-2027) Figure 21. Europe Nonalcoholic Steatohepatitis Treatment Sales (Million USD) Growth Rate (2016-2027) Figure 22. China Nonalcoholic Steatohepatitis Treatment Revenue (Million USD) Growth Rate (2016-2027) Figure 23. China Nonalcoholic Steatohepatitis Treatment Sales (Million USD) and Growth Rate (2016-2027) Figure 24. Japan Nonalcoholic Steatohepatitis Treatment Revenue (Million USD) Growth Rate (2016-2027) Figure 25. Japan Nonalcoholic Steatohepatitis Treatment Sales (Million USD) Growth Rate (2016-2027) Figure 26. Southeast Asia Nonalcoholic Steatohepatitis Treatment Revenue (Million USD) Growth Rate (2016-2027) Figure 27. Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales (Million USD) Growth Rate (2016-2027) Figure 28. India Nonalcoholic Steatohepatitis Treatment Revenue (Million USD) Growth Rate (2016-2027) Figure 29. India Nonalcoholic Steatohepatitis Treatment Sales (Million USD) Growth Rate (2016-2027) Figure 30. Global 5 Largest Nonalcoholic Steatohepatitis Treatment Players Market Share by Revenue in Nonalcoholic Steatohepatitis Treatment: 2016 & 2020 Figure 31. Nonalcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 32. Global Nonalcoholic Steatohepatitis Treatment Revenue Share by Type (2016-2021) Figure 33. Global Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate by Type in 2016 & 2020 Figure 34. Global Nonalcoholic Steatohepatitis Treatment Revenue Share by Application (2016-2021) Figure 35. Global Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate by Application in 2016 & 2020 Figure 36. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type in 2020 Figure 37. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application in 2020 Figure 38. Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type in 2020 Figure 39. Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application in 2020 Figure 40. China Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type in 2020 Figure 41. China Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application in 2020 Figure 42. Japan Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type in 2020 Figure 43. Japan Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application in 2020 Figure 44. Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type in 2020 Figure 45. Southeast Asia Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application in 2020 Figure 46. India Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type in 2020 Figure 47. India Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application in 2020 Figure 48. Key Raw Materials Price Trend Figure 49. Manufacturing Cost Structure of Nonalcoholic Steatohepatitis Treatment Figure 50. Manufacturing Process Analysis of Nonalcoholic Steatohepatitis Treatment Figure 51. Nonalcoholic Steatohepatitis Treatment Industrial Chain Analysis Figure 52. Channels of Distribution Figure 53. Distributors Profiles Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

AstraZeneca Arena Pharmaceuticals GSK Novo Nordisk Roche Vivus Arisaph Pharmaceuticals Cempra Pharmaceuticals Galectin Therapeutics Galmed Pharmaceuticals Genfit Gilead